Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Metastatic Colon Carcinoma: early-phase trial registry

1 of 4 indexed Metastatic Colon Carcinoma trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count

Metastatic Colon Carcinoma: 4 US clinical trials tracked, 1 recruiting.

Metastatic Colon Carcinoma is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Howard S. Hochster, MD, running 1 of these trials.

Enrollment posture brief

Registry condition metastatic-colon-carcinoma

OPEN 1 | RECR 25% | LATE 0 | EARLY 3 | RANK #4115 | SPON 1

Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Metastatic Colon Carcino (th…25%
Open-enrollment share among volume-matched conditions near Metastatic Colon Carcinoma

Metastatic Colon Carcinoma lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Metastatic Colon Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Metastatic Colon Carcinoma is recruiting below its size-band peers.

    1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11Phase 22

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 2

Named interventions

Most-linked intervention names on Metastatic Colon Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

pancreatectomy or hepatectomy Procedure
1 trials
MVT-5873 Drug
1 trials
Trifluridine and Tipiracil Hydrochloride Drug
1 trials
Patient Monitoring Procedure
1 trials
NBT-NM108 Drug
1 trials
Trametinib Drug
1 trials
Best Practice Other
1 trials
Questionnaire Administration Other
1 trials

US sites by state

Facility locations filed on Metastatic Colon Carcinoma trials. A trial with sites in several states counts in each.

Texas 1 trials
New Jersey 1 trials
Maryland 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Metastatic Colon Carcinoma page

4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Metastatic Colon Carcinoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Howard S. Hochster, MD sponsors the most Metastatic Colon Carcinoma trials on record, review their full trial history before evaluating a specific study. See Howard S. Hochster, MD's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Metastatic Colon Carcinoma condition card totals 4 registered trials; most-linked intervention pancreatectomy or hepatectomy; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.